Ubs Group Ag Cabaletta Bio, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 22,774 shares of CABA stock, worth $52,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,774

Previous 68,573 66.79%

Holding current value

$52,835

Previous $512,000 79.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.94 - $8.24 $180,448 - $377,383	-45,799 Reduced 66.79%	22,774 $107,000
Q2 2024 Aug 13, 2024	SELL	$7.22 - $18.82 $1.02 Million - $2.65 Million	-140,903 Reduced 67.26%	68,573 $512,000
Q1 2024 May 13, 2024	BUY	$16.79 - $25.38 $1.19 Million - $1.8 Million	70,831 Added 51.09%	209,476 $3.57 Million
Q4 2023 Feb 09, 2024	BUY	$12.21 - $23.36 $1.27 Million - $2.42 Million	103,662 Added 296.32%	138,645 $3.15 Million
Q3 2023 Nov 09, 2023	BUY	$11.84 - $18.65 $237,545 - $374,174	20,063 Added 134.47%	34,983 $532,000
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $101,745 - $185,535	13,300 Added 820.99%	14,920 $192,000
Q1 2023 May 12, 2023	BUY	$7.08 - $12.62 $523 - $933	74 Added 4.79%	1,620 $13,000
Q4 2022 Feb 08, 2023	SELL	$0.64 - $9.3 $31,010 - $450,622	-48,454 Reduced 96.91%	1,546 $14,000
Q3 2022 Nov 10, 2022	BUY	$0.63 - $2.05 $31,500 - $102,499	50,000 New	50,000 $33,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $3,239 - $14,112	-964 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $5,187 - $9,262	741 Added 332.29%	964 $12,000
Q2 2021 Aug 13, 2021	SELL	$7.2 - $11.73 $5,169 - $8,422	-718 Reduced 76.3%	223 $2,000
Q1 2021 May 12, 2021	SELL	$10.39 - $14.53 $10,348 - $14,471	-996 Reduced 51.42%	941 $10,000
Q4 2020 Feb 11, 2021	BUY	$9.81 - $15.8 $17,383 - $27,997	1,772 Added 1073.94%	1,937 $24,000
Q3 2020 Nov 12, 2020	SELL	$9.71 - $14.41 $42,568 - $63,173	-4,384 Reduced 96.37%	165 $2,000
Q2 2020 Jul 31, 2020	BUY	$6.39 - $11.28 $4,415 - $7,794	691 Added 17.91%	4,549 $51,000
Q1 2020 May 01, 2020	SELL	$6.0 - $18.67 $25,104 - $78,115	-4,184 Reduced 52.03%	3,858 $28,000
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $63,370 - $142,423	8,042 New	8,042 $112,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $67.3M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account